Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New study tests better pain relief after liver surgery

NCT ID NCT03238430

Symptom relief Sponsor: University Hospital, Lille Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at two methods to control pain after liver surgery: continuous wound infiltration with a local anesthetic (ropivacaine) and a single spinal injection of morphine. The goal was to see which approach reduces the need for additional morphine and lowers the chance of chronic pain at 3 and 6 months after surgery. A total of 186 patients took part, and the results could help improve recovery after liver operations.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Ropivacaine and intrathecal morphine
What this could lead to
If successful, this could show that one of these methods is better at controlling pain after liver surgery, reducing the need for morphine and lowering the risk of long-term pain.
What could go wrong
This is a completed Phase 2/3 trial with 186 participants, so results are available but may not apply to all patients. The study compares existing techniques, so no breakthrough is expected.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Phase 2/3

Runs two stages together: whether the treatment works, then large-scale confirmation.

Participants

186 people

The number who actually took part.

Started

May 2015

Finished

May 2019

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Surgery of hepatic resection by first under costal. * Patient classified ASA 1 to 3. * Information, signed and informed consent Exclusion Criteria: * Patients classified ASA 4 or 5. * Allergy or intolerance to any of the products used in the protocol. * Emergency surgery, palliative surgery, surgical recovery. * History of chronic pain requiring the regular use of analgesics, especially opioids. * History of drug misuse. * Inability to understand and / or use the patient's self-controlled morphine pump. * Known history of psychiatric disorders or current psychotropic treatment (excluding benzodiazepine monotherapy) * Additive behavior with respect to alcohol or non-weaned psychodysleptic substances * Pregnant Woman or Breastfeeding

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Pain, postoperative are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Pain, Postoperative

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Pain, postoperative

Contacts and locations

Locations

  • CHRU , Hôpital Claude Huriez

    Lille, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.